[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @NachoTrust In Nacho We Trust In Nacho We Trust posts on X about $rvmd, $imrx, ras, bitcoin the most. They currently have XXXXX followers and XXX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::710286564908253184/interactions)  - X Week XXX -XX% - X Month XXXXX +153% - X Months XXXXXX +886% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::710286564908253184/posts_active)  - X Week XX +120% - X Month XX +33% - X Months XX +315% - X Year XX +139% ### Followers: XXXXX [#](/creator/twitter::710286564908253184/followers)  - X Week XXXXX +0.11% - X Month XXXXX +0.33% - X Months XXXXX +0.45% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::710286564908253184/influencer_rank)  ### Social Influence [#](/creator/twitter::710286564908253184/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) [stocks](/list/stocks) **Social topic influence** [$rvmd](/topic/$rvmd) #17, [$imrx](/topic/$imrx) #23, [ras](/topic/ras), [bitcoin](/topic/bitcoin), [why is](/topic/why-is), [its just](/topic/its-just), [$125150share](/topic/$125150share), [targets](/topic/targets), [$750m1bn](/topic/$750m1bn) **Top assets mentioned** [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Bitcoin (BTC)](/topic/bitcoin) ### Top Social Posts [#](/creator/twitter::710286564908253184/posts) --- Top posts by engagements in the last XX hours "@LPessa7654 @Jonny_fun_guy Many reasons why $imrx will never be $rvmd. Their own candidate has very little response in monotherapy for starters. Furthermore $rvmd has not even shown its 1L data yet I suspect its gonna be very good. Sell IMRX while you can" [X Link](https://x.com/NachoTrust/status/1976819081375629387) [@NachoTrust](/creator/x/NachoTrust) 2025-10-11T01:16Z 3600 followers, XXX engagements "@broheim777 $imrx candidate as limited response in monotherapy plus no report of pfs. Data not even better than daraxonrasib mono in 2L setting. There are more players than $rvmd out there in the RAS - you should perhaps read up a little" [X Link](https://x.com/NachoTrust/status/1978573851870081297) [@NachoTrust](/creator/x/NachoTrust) 2025-10-15T21:29Z 3600 followers, XXX engagements "@PeterSchiff @JamesHMackay why is bitcoin trading down bruuuuhh" [X Link](https://x.com/NachoTrust/status/1978976257128960119) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T00:08Z 3600 followers, XXX engagements "@JamesHMackay @PeterSchiff I will buy and hopefully then it crashes" [X Link](https://x.com/NachoTrust/status/1978978782263345580) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T00:18Z 3600 followers, XX engagements "@JamesHMackay @PeterSchiff A broken clock can be right some times too nows the time James. Get out while you still can" [X Link](https://x.com/NachoTrust/status/1978988242180378770) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T00:55Z 3600 followers, XX engagements "@JamesHMackay @PeterSchiff Ok. Will be on the look out for that range" [X Link](https://x.com/NachoTrust/status/1979006182141382710) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T02:06Z 3600 followers, XX engagements "@3PeaksTrading I think it can happen sooner rather than later. Merck needs this. Its just a year of keytruda revenue needed to get it $125-150/share instantly become a leader in the biggest oncology targets" [X Link](https://x.com/NachoTrust/status/1979007872810766337) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T02:13Z 3600 followers, XX engagements "@bio_clouseau Seriously $rvmd has fully recruited its phase X 2L trial well ahead of schedule and plus this that a lot of saved time probably means $750m-1bn of earlier than expected revenue of not more which may result in not needing another equity issue" [X Link](https://x.com/NachoTrust/status/1979149635995472200) [@NachoTrust](/creator/x/NachoTrust) 2025-10-17T11:36Z 3600 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
In Nacho We Trust posts on X about $rvmd, $imrx, ras, bitcoin the most. They currently have XXXXX followers and XXX posts still getting attention that total X engagements in the last XX hours.
Social category influence cryptocurrencies stocks
Social topic influence $rvmd #17, $imrx #23, ras, bitcoin, why is, its just, $125150share, targets, $750m1bn
Top assets mentioned Revolution Medicines, Inc. Common Stock (RVMD) Bitcoin (BTC)
Top posts by engagements in the last XX hours
"@LPessa7654 @Jonny_fun_guy Many reasons why $imrx will never be $rvmd. Their own candidate has very little response in monotherapy for starters. Furthermore $rvmd has not even shown its 1L data yet I suspect its gonna be very good. Sell IMRX while you can"
X Link @NachoTrust 2025-10-11T01:16Z 3600 followers, XXX engagements
"@broheim777 $imrx candidate as limited response in monotherapy plus no report of pfs. Data not even better than daraxonrasib mono in 2L setting. There are more players than $rvmd out there in the RAS - you should perhaps read up a little"
X Link @NachoTrust 2025-10-15T21:29Z 3600 followers, XXX engagements
"@PeterSchiff @JamesHMackay why is bitcoin trading down bruuuuhh"
X Link @NachoTrust 2025-10-17T00:08Z 3600 followers, XXX engagements
"@JamesHMackay @PeterSchiff I will buy and hopefully then it crashes"
X Link @NachoTrust 2025-10-17T00:18Z 3600 followers, XX engagements
"@JamesHMackay @PeterSchiff A broken clock can be right some times too nows the time James. Get out while you still can"
X Link @NachoTrust 2025-10-17T00:55Z 3600 followers, XX engagements
"@JamesHMackay @PeterSchiff Ok. Will be on the look out for that range"
X Link @NachoTrust 2025-10-17T02:06Z 3600 followers, XX engagements
"@3PeaksTrading I think it can happen sooner rather than later. Merck needs this. Its just a year of keytruda revenue needed to get it $125-150/share instantly become a leader in the biggest oncology targets"
X Link @NachoTrust 2025-10-17T02:13Z 3600 followers, XX engagements
"@bio_clouseau Seriously $rvmd has fully recruited its phase X 2L trial well ahead of schedule and plus this that a lot of saved time probably means $750m-1bn of earlier than expected revenue of not more which may result in not needing another equity issue"
X Link @NachoTrust 2025-10-17T11:36Z 3600 followers, XXX engagements
/creator/twitter::NachoTrust